Dow Up0.35% Nasdaq Down0.02%

Endocyte, Inc. (ECYT)

6.48 0.17(2.56%) Aug 20, 4:00PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.2
Mean Recommendation (last week):2.2

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:13.00
Median Target:9.00
High Target:26.00
Low Target:6.00
No. of Brokers:9

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
May 2, 2014Robert W. BairdDowngradeOutperformNeutral
Sep 30, 2013Chardan Capital MarketsInitiated Buy
Mar 25, 2013Robert W. BairdUpgradeNeutralOutperform
Nov 20, 2012Summer Street ResearchInitiated Buy
Mar 17, 2011RBC Capital MktsInitiated Outperform
Mar 16, 2011Robert W. BairdInitiated Outperform
Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy2222

Data provided by Thomson/First Call

Currency in USD.